Quest Diagnostics (DGX) Tops Q1 EPS by 25c, Raises FY EPS Guidance
Tweet
Share
E-mail
Get Alerts DGX Hot Sheet
Price: $212.38 -0.5%
EPS Growth %: +7.6%
Financial Fact:
Net income: 205M
Today's EPS Names:
EPAC, SAR, KRUS, More
EPS Growth %: +7.6%
Financial Fact:
Net income: 205M
Today's EPS Names:
EPAC, SAR, KRUS, More
Join SI Premium – FREE
Quest Diagnostics (NYSE: DGX) reported Q1 EPS of $3.22, $0.25 better than the analyst estimate of $2.97. Revenue for the quarter came in at $2.61 billion versus the consensus estimate of $2.63 billion.
GUIDANCE:
Quest Diagnostics sees FY2022 EPS of $9.00-$9.50, versus the consensus of $9.03.
For earnings history and earnings-related data on Quest Diagnostics (DGX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Kura Sushi (KRUS) Tops Q3 EPS by 3c; offers outlook
- Raymond James Starts Wintrust Financial (WTFC) at Outperform
- Freedom Broker Starts PBF Energy (PBF) at Hold
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
